These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24603328)

  • 61. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
    Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
    JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
    Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
    J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.
    Gambini C; Conte M; Bernini G; Angelini P; Pession A; Paolucci P; Donfrancesco A; Veneselli E; Mazzocco K; Tonini GP; Raffaghello L; Dominici C; Morando A; Negri F; Favre A; De Bernardi B; Pistoia V
    Virchows Arch; 2003 Jun; 442(6):555-62. PubMed ID: 12709798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ALK amplification and protein expression predict inferior prognosis in neuroblastomas.
    Wang M; Zhou C; Sun Q; Cai R; Li Y; Wang D; Gong L
    Exp Mol Pathol; 2013 Oct; 95(2):124-30. PubMed ID: 23797004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.
    Nozato M; Kaneko S; Nakagawara A; Komuro H
    Int J Oncol; 2013 Jan; 42(1):134-40. PubMed ID: 23135478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hedgehog signaling pathway in neuroblastoma differentiation.
    Souzaki R; Tajiri T; Souzaki M; Kinoshita Y; Tanaka S; Kohashi K; Oda Y; Katano M; Taguchi T
    J Pediatr Surg; 2010 Dec; 45(12):2299-304. PubMed ID: 21129534
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
    Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
    Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies.
    Yao ZG; Liu XM; Qin YJ
    Fetal Pediatr Pathol; 2016; 35(6):410-415. PubMed ID: 27362946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. INSM1 Expression in Peripheral Neuroblastic Tumors and Other Embryonal Neoplasms.
    Wang H; Krishnan C; Charville GW
    Pediatr Dev Pathol; 2019 Oct; 22(5):440-448. PubMed ID: 30975032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
    Molenaar WM; Baker DL; Pleasure D; Lee VM; Trojanowski JQ
    Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.
    Veschi V; Petroni M; Cardinali B; Dominici C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Giannini G
    PLoS One; 2012; 7(11):e49139. PubMed ID: 23152863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
    Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
    J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.
    He WG; Yan Y; Tang W; Cai R; Ren G
    Oncotarget; 2017 Jun; 8(23):37730-37739. PubMed ID: 28465480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
    Hicks MJ; Mackay B
    Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
    George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas.
    Muñoz J; Vendrell E; Aiza G; Nistal M; Pestaña A; Peinado MA; Castresana JS
    Neuropathology; 2006 Jun; 26(3):165-9. PubMed ID: 16771170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic score.
    Klijanienko J; Couturier J; Brisse H; Pierron G; Fréneaux P; Berger F; Maciorowski Z; Sastre-Garau X; Michon J; Schleiermacher G
    Cancer Cytopathol; 2011 Dec; 119(6):411-23. PubMed ID: 21774092
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.